for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Teva buys Allergan for $40.5 billion

Posted

Analysts say Allergan's betting it'll get further growth from its branded drugs business by selling its generics unit, so look for more deals. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up